Medical News Today (MNT)Is Your Cholesterol Too High per the New ACC/AHA Guideline? 5 Things to Know

👥 Patient Education / Counseling Guidance

The 2026 ACC/AHA Dyslipidemia Guideline shifts cholesterol management toward risk-based treatment while reintroducing defined LDL-C goals. Major updates include universal lipoprotein(a) testing, the PREVENT risk calculator, expanded childhood screening, and broader use of coronary artery calcium scoring.

Patient Counseling Points

• Guideline recommendations now incorporate overall cardiovascular risk, not LDL-C levels alone.
• One-time Lp(a) testing may identify inherited cardiovascular risk missed by standard lipid panels.
• Coronary artery calcium scoring may refine treatment decisions when risk remains uncertain.
• New LDL-C goals are generally lower for high-risk and very high-risk individuals.

Patient Care Applications

• Interpret LDL-C results within overall cardiovascular risk profiles.
• Recognize elevated Lp(a) as a potential inherited risk enhancer.
• Reassure patients that treatment targets are individualized, not universal.
• Redirect statin-intolerant patients toward discussion of evidence-based alternatives.